| Literature DB >> 33589622 |
Lisenn Lalier1,2, Vincent Mignard1,2, Marie-Pierre Joalland1,2, Didier Lanoé1,2, Pierre-François Cartron1,2, Stéphen Manon3, François M Vallette4,5.
Abstract
In this work, we have explored the subcellular localization of Bcl2, a major antiapoptotic protein. In U251 glioma cells, we found that Bcl2 is localized mainly in the ER and is translocated to MAM and mitochondria upon induction of apoptosis; this mitochondrial transfer was not restricted to the demonstrator cell line, even if cell-specific modulations exist. We found that the Bcl2/mitochondria interaction is controlled by TOM20, a protein that belongs to the protein import machinery of the mitochondrial outer membrane. The expression of a small domain of interaction of TOM20 with Bcl2 potentiates its anti-apoptotic properties, which suggests that the Bcl2-TOM20 interaction is proapoptotic. The role of MAM and TOM20 in Bcl2 apoptotic mitochondrial localization and function has been confirmed in a yeast model in which the ER-mitochondria encounter structure (ERMES) complex (required for MAM stability in yeast) has been disrupted. Bcl2-TOM20 interaction is thus an additional player in the control of apoptosis.Entities:
Year: 2021 PMID: 33589622 PMCID: PMC7884705 DOI: 10.1038/s41419-021-03471-8
Source DB: PubMed Journal: Cell Death Dis Impact factor: 8.469